NLC Health Ventures

Firm Name: NLC Health Ventures Investment Thesis: Building and co-founding early-stage healthtech and biotech ventures to advance patient-centered innovation. Focus: Biotech, Medtech, Digital Health, Diagnostics, Spanning therapeutics, surgical tools, enterprise health software. Stage: Pre-seed to Series A–B (initial investment in venture creation with follow-on rounds up to ~€9M per company) Geography: Amsterdam HQ, active across Europe (16+ countries) and expanding globally (notably via U.S. partnerships) Notable Portfolio Companies: Altach, POROUS, Exolvo, NeurOdys Therapeutics, Sigilla Medical, Crainio Description: Founded in 2014 and headquartered at the Amsterdam Health & Technology Center, NLC Health Ventures is a leading European healthtech venture builder and early-stage VC. They bridge the gap between scientific breakthroughs and patient-ready solutions by sourcing innovations from academia, hospitals, and corporates—evaluating over 1,500 annually—and co-founding around 20 new ventures in 2024 alone